Home  >  Products  >  SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)) Blocking Peptide (the N terminal of protein) (100ug)
SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)) Blocking Peptide (the N terminal of protein) (100ug)

SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SRC antibody (Catalogue #: ARP32476_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP32476
Size: 100 ug
Weight: 60kDa
Gene: 6714
Format: Lyophilized powder
Target: This gene is highly similar to the v-src gene of Rous sarcoma virus. This proto-oncogene may play a role in the regulation of embryonic development and cell growth. SRC protein is a tyrosine-protein kinase whose activity can be inhibited by phosphorylation by c-SRC kinase. Mutations in this gene could be involved in the malignant progression of colon cancer.This gene is highly similar to the v-src gene of Rous sarcoma virus. This proto-oncogene may play a role in the regulation of embryonic development and cell growth. The protein encoded by this gene is a tyrosine-protein kinase whose activity can be inhibited by phosphorylation by c-SRC kinase. Mutations in this gene could be involved in the malignant progression of colon cancer. Two transcript variants encoding the same protein have been found for this gene.
Alternative names: ASV; SRC1; c-SRC; p60-Src
See Full Product Listings >